Adding to the confusion in more than name
Clin Mol Hepatol. 2023 Sep 18. doi: 10.3350/cmh.2023.0367. Online ahead of print.NO ABSTRACTPMID:37718551 | DOI:10.3350/cmh.2023.0367 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Jacob George Source Type: research
From NASH, MAFLD, to SLD: updates of nomenclature and impact on clinical trials
Clin Mol Hepatol. 2023 Sep 18. doi: 10.3350/cmh.2023.0359. Online ahead of print.NO ABSTRACTPMID:37718552 | DOI:10.3350/cmh.2023.0359 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Ming-Lun Yeh Ming-Lung Yu Source Type: research
Correspondence on Letter regarding "Risk factors in nonalcoholic fatty liver disease"
Clin Mol Hepatol. 2023 Aug 29. doi: 10.3350/cmh.2023.0310. Online ahead of print.NO ABSTRACTPMID:37718595 | DOI:10.3350/cmh.2023.0310 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Eileen L Yoon Dae Won Jun Source Type: research
Adding to the confusion in more than name
Clin Mol Hepatol. 2023 Sep 18. doi: 10.3350/cmh.2023.0367. Online ahead of print.NO ABSTRACTPMID:37718551 | DOI:10.3350/cmh.2023.0367 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Jacob George Source Type: research
From NASH, MAFLD, to SLD: updates of nomenclature and impact on clinical trials
Clin Mol Hepatol. 2023 Sep 18. doi: 10.3350/cmh.2023.0359. Online ahead of print.NO ABSTRACTPMID:37718552 | DOI:10.3350/cmh.2023.0359 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Ming-Lun Yeh Ming-Lung Yu Source Type: research
Correspondence on Letter regarding "Risk factors in nonalcoholic fatty liver disease"
Clin Mol Hepatol. 2023 Aug 29. doi: 10.3350/cmh.2023.0310. Online ahead of print.NO ABSTRACTPMID:37718595 | DOI:10.3350/cmh.2023.0310 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Eileen L Yoon Dae Won Jun Source Type: research
Adding to the confusion in more than name
Clin Mol Hepatol. 2023 Sep 18. doi: 10.3350/cmh.2023.0367. Online ahead of print.NO ABSTRACTPMID:37718551 | DOI:10.3350/cmh.2023.0367 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Jacob George Source Type: research
From NASH, MAFLD, to SLD: updates of nomenclature and impact on clinical trials
Clin Mol Hepatol. 2023 Sep 18. doi: 10.3350/cmh.2023.0359. Online ahead of print.NO ABSTRACTPMID:37718552 | DOI:10.3350/cmh.2023.0359 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Ming-Lun Yeh Ming-Lung Yu Source Type: research
Correspondence on Letter regarding "Risk factors in nonalcoholic fatty liver disease"
Clin Mol Hepatol. 2023 Aug 29. doi: 10.3350/cmh.2023.0310. Online ahead of print.NO ABSTRACTPMID:37718595 | DOI:10.3350/cmh.2023.0310 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Eileen L Yoon Dae Won Jun Source Type: research
Adding to the confusion in more than name
Clin Mol Hepatol. 2023 Sep 18. doi: 10.3350/cmh.2023.0367. Online ahead of print.NO ABSTRACTPMID:37718551 | DOI:10.3350/cmh.2023.0367 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Jacob George Source Type: research
From NASH, MAFLD, to SLD: updates of nomenclature and impact on clinical trials
Clin Mol Hepatol. 2023 Sep 18. doi: 10.3350/cmh.2023.0359. Online ahead of print.NO ABSTRACTPMID:37718552 | DOI:10.3350/cmh.2023.0359 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Ming-Lun Yeh Ming-Lung Yu Source Type: research
Correspondence on Letter regarding "Risk factors in nonalcoholic fatty liver disease"
Clin Mol Hepatol. 2023 Aug 29. doi: 10.3350/cmh.2023.0310. Online ahead of print.NO ABSTRACTPMID:37718595 | DOI:10.3350/cmh.2023.0310 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 18, 2023 Category: Gastroenterology Authors: Eileen L Yoon Dae Won Jun Source Type: research
Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: a longitudinal real-world study
CONCLUSION: Compared to White patients, Black patients with NAFLD were at the highest risk for overall and non-liver-related mortality, followed by Hispanic patients with Asian patients at the lowest risk for all adverse outcomes. Culturally sensitive and appropriate programs may be needed for more successful interventions.PMID:37691484 | DOI:10.3350/cmh.2023.0205 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - September 11, 2023 Category: Gastroenterology Authors: Vy H Nguyen Isaac Le Audrey Ha Richard Hieu Le Nicholas Ajit Rouillard Ashley Fong Surya Gudapati Jung Eun Park Mayumi Maeda Scott Barnett Ramsey Cheung Mindie H Nguyen Source Type: research
